|
Neurology 2002;59:560-562 © 2002 American Academy of Neurology Transcranial magnetic stimulation for the treatment of seizuresA controlled studyFrom the Clinical Epilepsy (Drs. Theodore, Hunter, and VegaBermudez, and P. ReevesTyler and K. Kelley) and Human Cortical Physiology Sections (Drs. Chen, Boroojerdi, Werhahn, and Cohen), National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD. Address correspondence and reprint requests to William H. Theodore, MD, NIH, Bldg. 10, Rm. 5N-250, Bethesda, MD 20892; e-mail: theodorw{at}ninds.nih.gov Objective: To perform a controlled trial of transcranial magnetic stimulation (TMS). Methods: Twenty-four patients with localization-related epilepsy were randomized to blinded active or placebo stimulation. Weekly seizure frequency was compared for 8 weeks before and after 1 week of 1-Hz TMS for 15 minutes twice daily. Results: When the 8-week baseline and post-stimulation periods were compared, active patients had a mean seizure frequency reduction of 0.045 ± 0.13 and sham-stimulated control subjects -0.004 ± 0.20. Over 2 weeks, actively treated patients had a mean reduction in weekly seizure frequency of 0.16 ± 0.18 and sham-stimulated control subjects 0.01 ± 0.24. Neither difference was significant. Conclusion: The effect of TMS on seizure frequency was mild and short lived. This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||